Immunocompromised patients
Intended Learning Outcomes
| Immunocompromised Patients Part 1: Recognizing the Immunocompromised Patient in the ICU |
- Define an approach to the identification of an immunocompromised patient
- Appreciate the utility (and limitations) of imaging, microbiological, and serologic testing for diagnosing infection in the immunocompromised patient
- Understand the promise, and present limitations, of new biochemical markers of infection and molecular diagnostic techniques for diagnosing infection in this patient population
|
| Immunocompromised Patients Part 2: Mechanisms of Acquired Immunodeficiency |
- Understand the elements of a normally functioning immune system
- List non-pharmacological and pharmacological mechanisms for acquired immunodeficiency
- Appreciate the potential for immunomodulatory therapies in the septic patient
|
| Immunocompromised Patients Part 3: Managing the Immunocompromised Patient |
- Define an approach to diagnosing and treating infection in a neutropenic patient
- Identify time periods of susceptibility and the different pathogens responsible for infection following solid organ transplant
- Identify time periods of susceptibility and the different pathogens responsible for infection following haematopoetic stem cell transplant
|
| Immunocompromised Patients Part 4: Preventing Infection in the immunocompromised patient |
- Identify the most important and effective intervention for reducing infection in the ICU
- Discuss the pros and cons of infection prevention measures in the ICU, and how they can protect the immunocompromised patient
- Define the clinical situations where antimicrobial prophylaxis is warranted
|
Relevant Competencies from CoBaTrICE
| Immunocompromised Patients Part 1: Recognizing the Immunocompromised Patient in the ICU |
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 2.2 Undertakes timely and appropriate investigations
- 2.10 Integrates clinical findings with laboratory investigations to form a differential diagnosis
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
|
| Immunocompromised Patients Part 2: Mechanisms of Acquired Immunodeficiency |
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 2.2 Undertakes timely and appropriate investigations
- 2.10 Integrates clinical findings with laboratory investigations to form a differential diagnosis
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
|
| Immunocompromised Patients Part 3: Managing the Immunocompromised Patient |
- 1.1 Adopts a structured and timely approach to the recognition, assessment and stabilisation of the acutely ill patient with disordered physiology
- 2.2 Undertakes timely and appropriate investigations
- 4.2 Manages antimicrobial drug therapy
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
|
| Immunocompromised Patients Part 4: Preventing Infection in the immunocompromised patient |
- 7.1 Identifies and attempts to minimise the physical and psychosocial consequences of critical illness for patients and families
- 11.2 Complies with local infection control measures
- 11.3 Identifies environmental hazards and promotes safety for patients & staff
- 11.6 Critically appraises and applies guidelines, protocols and care bundles
|
Faculty Disclosures:
The authors of this module have not reported any disclosures.
Copyright©2017. European Society of Intensive Care Medicine. All rights reserved.
ISBN 978-92-95051-83-6 - Legal deposit D/2005/10.772/30
